-
Something wrong with this record ?
The Effects of Hyperemesis Gravidarum on the Oral Glucose Tolerance Test Values and Gestational Diabetes
B. Bayraktar, M. Balıkoğlu, M. G. Bayraktar, A. G. Kanmaz
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2012
Medline Complete (EBSCOhost)
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
- MeSH
- Diabetes, Gestational * diagnosis MeSH
- Glucose Tolerance Test MeSH
- Hyperemesis Gravidarum * diagnosis MeSH
- Blood Glucose MeSH
- Humans MeSH
- Infant, Newborn MeSH
- Blood Glucose Self-Monitoring MeSH
- Pregnancy MeSH
- Check Tag
- Humans MeSH
- Infant, Newborn MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
This study is aimed at determination whether pregnant women who develop hyperemesis gravidarum in the first trimester have a tendency to develop gestational diabetes mellitus (GDM). It is also aimed at identification of effects of hyperemesis gravidarum and GDM on prenatal and neonatal status in case they were detected together. Hyperemesis gravidarum diagnose was based on the following signs and symptoms. To diagnose GDM, first trimester fasting blood glucose measurement and subsequent blood glucose monitoring and 75-g oral glucose tolerance test (OGTT) were performed in the second trimester. A total of 949 singleton pregnant women (95 with and 852 without hyperemesis gravidarum) who met our criteria were included in the study. In the first trimester, plasma blood glucose and positive GDM screening were found to be significantly higher in the hyperemesis gravidarum group compared to the control group (p=0.042 and p<0.001, respectively). However, actual GDM cases were similar between both groups. The positive predictive value was significantly lower in the hyperemesis gravidarum group (28.5% vs. 72.7%, p=0.003). In the second trimester, the prevalence of GDM was 6.6% in the hyperemesis gravidarum group and 7.3% in the control group, with no significant difference (p=0.218) between-groups. In this study, hyperemesis gravidarum was found to cause changes in maternal metabolism in the first trimester of pregnancy due to limited calorie intake and fasting; in the presence of hyperemesis gravidarum, it should be known that the positive predictive value of first trimester gestational diabetes screening may decrease and the diagnosis of pseudo-GDM may increase.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22000784
- 003
- CZ-PrNML
- 005
- 20220310105604.0
- 007
- ta
- 008
- 220106s2021 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/23362936.2021.26 $2 doi
- 035 __
- $a (PubMed)34924106
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Bayraktar, Burak $u Department of Obstetrics and Gynecology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey
- 245 14
- $a The Effects of Hyperemesis Gravidarum on the Oral Glucose Tolerance Test Values and Gestational Diabetes / $c B. Bayraktar, M. Balıkoğlu, M. G. Bayraktar, A. G. Kanmaz
- 504 __
- $a Literatura
- 520 9_
- $a This study is aimed at determination whether pregnant women who develop hyperemesis gravidarum in the first trimester have a tendency to develop gestational diabetes mellitus (GDM). It is also aimed at identification of effects of hyperemesis gravidarum and GDM on prenatal and neonatal status in case they were detected together. Hyperemesis gravidarum diagnose was based on the following signs and symptoms. To diagnose GDM, first trimester fasting blood glucose measurement and subsequent blood glucose monitoring and 75-g oral glucose tolerance test (OGTT) were performed in the second trimester. A total of 949 singleton pregnant women (95 with and 852 without hyperemesis gravidarum) who met our criteria were included in the study. In the first trimester, plasma blood glucose and positive GDM screening were found to be significantly higher in the hyperemesis gravidarum group compared to the control group (p=0.042 and p<0.001, respectively). However, actual GDM cases were similar between both groups. The positive predictive value was significantly lower in the hyperemesis gravidarum group (28.5% vs. 72.7%, p=0.003). In the second trimester, the prevalence of GDM was 6.6% in the hyperemesis gravidarum group and 7.3% in the control group, with no significant difference (p=0.218) between-groups. In this study, hyperemesis gravidarum was found to cause changes in maternal metabolism in the first trimester of pregnancy due to limited calorie intake and fasting; in the presence of hyperemesis gravidarum, it should be known that the positive predictive value of first trimester gestational diabetes screening may decrease and the diagnosis of pseudo-GDM may increase.
- 650 _2
- $a krevní glukóza $7 D001786
- 650 _2
- $a selfmonitoring glykemie $7 D015190
- 650 12
- $a gestační diabetes $x diagnóza $7 D016640
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glukózový toleranční test $7 D005951
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hyperemesis gravidarum $x diagnóza $7 D006939
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a těhotenství $7 D011247
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Balıkoğlu, Meriç $u Department of Obstetrics and Gynecology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey
- 700 1_
- $a Bayraktar, Miyase Gizem $u Department of Obstetrics and Gynecology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey
- 700 1_
- $a Kanmaz, Ahkam Goksel $u Department of Obstetrics and Gynecology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey
- 773 0_
- $w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 122, č. 4 (2021), s. 285-293
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34924106 $y Pubmed
- 910 __
- $a ABA008 $b A 7 $c 1071 $y p $z 0
- 990 __
- $a 20220106 $b ABA008
- 991 __
- $a 20220310105558 $b ABA008
- 999 __
- $a ok $b bmc $g 1761102 $s 1151930
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 122 $c 4 $d 285-293 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
- LZP __
- $b NLK118 $a Pubmed-20220106